Sean Armour, Head of Discovery, Spark Therapeutics
Monica Avila, Sr. Director CMC, Cellenkos
Francesca Barone, CSO, Candel Therapeutics
Mr Clayton Beard, Chief Scientific Officer and Site Head, BridgeBio Gene Therapy
Jaap Boelens, Chief, Stem Cell Transplantation And Cellular Therapies Pediatrics, Memorial Sloan-Kettering Cancer Center
Martin Bonamino, Head of the Cell and Gene Therapy Program at the National Cancer Institute of Brazil, National Cancer Institute of Brazil
Tara Britt, Founder and President, Rare Disease Innovations Institute, Inc.
PJ Brooks, Acting Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
Eric Michael David, Chief Executive Officer, BridgeBio Gene Therapy
Michele de Guise, President and Chief Executive Officer, INESSS
Marcie Finney, Executive Director, Cleveland Cord Blood Center
Gregory Fiore, Chief Executive Officer, Exacis Biotherapeutics
Miguel Forte, President Elect, ISCT; Entrepreneur in Residence, Adbio partners
David Greenwald, Vice President Of Business Development, Deerfield Management
Nader Halim, CEO, Innervace
Dr Patrick Hanley, Chief and Director, Cellular Therapy Program, Children's National Medical Center
Mr Robert Hofmeister, Chief Scientific Officer, Myeloid Therapeutics
Mr Jie Jia, Vice President, Strategic Alliances and Operations, Carsgen Therapeutics
Mr Scott Jones, VP of Scientific Affairs, BioBridge Global
Angela Justice, Chief People Officer, TCR² Therapeutics
Sven Kili, Principal, Sven Kili Consulting
Roland Kolbeck, Chief Scientific Officer, Spirovant Sciences
Mr Antti Kourula, Global Vice President, Commercial Development, Hematology, CSL Behring
Stephan Krause, Bristol Myers Squibb
Joanne Kurtzberg, Professor Of Pediatrics And Pathology; Director, Marcus Center For Cellular Cures,, Duke University Medical Center
Lawrence Lamb, Executive Vice President And Chief Scientific Officer, in8bio
Brett Logan, Former Director, U.S Public Payer Policy and Access Strategy, Alliance for Regenerative Medicine
Mr Steven Lucio, Senior Principal, Vizient
Mr Raymond Luke, Director, MSAT, Verismo Therapeutics
David Morrow, scientist, EATRIS
Snehal Naik, Head of Regulatory Policy; Strategy Leader (Ocular), Spark Therapeutics
Susan B Nichols, Chairman of the Board, Rare Disease Innovations Institute, Inc.
Charis Ober, Founder And Executive Director, Save the Cord Foundation
Raphael Ognar, President & Chief Executive Officer, Co-Founder, NKILT Therapeutics Inc.
Nneka Onwudiwe, Former PRO/PE Regulatory Review Officer, Food and Drug Administration (FDA)
Paul Orchard, Professor of Pediatrics, University of Minnesota
Kinnari Patel, President & COO, Rocket Pharma
David Peritt, Chief Scientific Officer, Lupagen
Frederick Porter, Chief Technical Officer, Taysha Gene Therapies
David Porter, Director, Cell Therapy and Transplant, University of Pennsylvania
Albert Ribickas, BMT Manager, Moffitt Cancer Center
Dr Kate Rochlin, Chief Operating Officer, in8bio
Tara Sadeghi, Chief Operating Officer, Cellenkos
Sumona (Fed) Sarkar, Biomedical Engineer, NIST USA
Machi Scaradavou, Medical Director Of The National Cord Blood Program, New York Blood Center
Ms Sonja Schrepfer, Scientific Founder and Senior Vice President at Sana Biotechnology (Head of Hypo-Immune Platform), Sana Biotechnology
Don Seigel, Professor, Pathology & Laboratory Medicine, University of Pennsylvania School Of Medicine
Robert Sexton, Vice President, Program and Alliance Leadership, Mustang Bio
Adam Shaywitz, Chief Medical Officer, BridgeBio Gene Therapy
Devyn Smith, Chief Executive Officer, Arbor Biotechnologies
Mr Morten Sogaard, President, Research and Technical Operations, Astellas Gene Therapies
Joseph Stavas, Senior Vice President of Clinical Development, ProKidney
Mr Michele Stone, Senior Vice President of Research and Development, Kriya Therapeutics
Paul Peter Tak, President & Chief Executive Officer, Candel Therapeutics
Dr Arun Upadhyay, Chief Scientific Officer, Ocugen
Mark Veich, VP, Philanthropy & Executive Director, The Deerfield Foundation and President of Advancium Health, Deerfield Foundation, Advancium Health
Get Involved with the Advanced Therapies Congress
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events